Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

NCT00377052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: bortezomib
DRUG: gemcitabine hydrochloride

Sponsor

NCIC Clinical Trials Group